193P Translational, PK, PD, and Immunophenotyping Analyses of Tuvusertib + Niraparib in a Phase Ib Open-Label Multicenter Dose-Escalation Study in Patients with Advanced Solid Tumors (ddriver Solid Tumors 301)
Annals of Oncology（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要